Thomas A Hughes

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Nanoscale

British journal of cancer

International journal of molecular sciences

Breast cancer research and treatment

University of Leeds

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Leeds

United Kingdom

Associate Prof of Cancer Biology :: School of Medicine

Publications

Yazan S Khaled, M Ibrahim Khot, Radhika Aiyappa-Maudsley, Thomas Maisey, Arindam Pramanik, Jim Tiernan, Nicole Lintern, Eiman Al-Enezi, Shazana H Shamsuddin, Darren Tomlinson, Louise Coletta, Paul A Millner, Thomas A Hughes, David G Jayne
Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle. Nanoscale 16 (14) (2024)
Yazan S Khaled, M Ibrahim Khot, Radhika Aiyappa-Maudsley, Thomas Maisey, Arindam Pramanik, Jim Tiernan, Nicole Lintern, Eiman Al-Enezi, Shazana H Shamsuddin, Darren Tomlinson, Louise Coletta, Paul A Millner, Thomas A Hughes, David G Jayne
Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle. Nanoscale 16 (14) (2024)
Yazan S Khaled, M Ibrahim Khot, Radhika Aiyappa-Maudsley, Thomas Maisey, Arindam Pramanik, Jim Tiernan, Nicole Lintern, Eiman Al-Enezi, Shazana H Shamsuddin, Darren Tomlinson, Louise Coletta, Paul A Millner, Thomas A Hughes, David G Jayne
Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle. Nanoscale (2024)
Yazan S Khaled, M Ibrahim Khot, Radhika Aiyappa-Maudsley, Thomas Maisey, Arindam Pramanik, Jim Tiernan, Nicole Lintern, Eiman Al-Enezi, Shazana H Shamsuddin, Darren Tomlinson, Louise Coletta, Paul A Millner, Thomas A Hughes, David G Jayne
Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle. Nanoscale 16 (14) (2024)
Radhika Aiyappa-Maudsley, Louis F V McLoughlin, Thomas A Hughes
Semaphorins and Their Roles in Breast Cancer: Implications for Therapy Resistance. International journal of molecular sciences 24 (17) (2023)
Arindam Pramanik, Zexi Xu, Nicola Ingram, Patricia Louise Coletta, Paul A Millner, Arwen I I Tyler, Thomas A Hughes
Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells. Molecular pharmaceutics 19 (12) (2022)
Arindam Pramanik, Zexi Xu, Shazana H Shamsuddin, Yazan S Khaled, Nicola Ingram, Thomas Maisey, Darren Charles Tomlinson, P Louise Coletta, David G Jayne, Thomas A Hughes, Arwen I I Tyler, Paul A Millner
Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using In Vitro and In Vivo Models. ACS applied materials & interfaces 14 (9) (2022)
Diana E Baxter, Lisa M Allinson, Waleed S Al Amri, James A Poulter, Arindam Pramanik, James L Thorne, Eldo T Verghese, Thomas A Hughes
MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer. Cancers 13 (23) (2021)
Noha Gwili, Stacey J Jones, Waleed Al Amri, Ian M Carr, Sarah Harris, Brian V Hogan, William E Hughes, Baek Kim, Fiona E Langlands, Rebecca A Millican-Slater, Arindam Pramanik, James L Thorne, Eldo T Verghese, Geoff Wells, Mervat Hamza, Layla Younis, Nevine M F El Deeb, Thomas A Hughes
Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response. British journal of cancer 125 (7) (2021)
Samantha A Hutchinson, Alex Websdale, Giorgia Cioccoloni, Hanne Røberg-Larsen, Priscilia Lianto, Baek Kim, Ailsa Rose, Chrysa Soteriou, Arindam Pramanik, Laura M Wastall, Bethany Jill Williams, Madeline A Henn, Joy J Chen, Liqian Ma, Jennifer Bernadette Moore, Erik Russell Nelson, Thomas A Hughes, James L Thorne
Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene 40 (16) (2021)
Robyn V Broad, Stacey J Jones, Melina C Teske, Laura M Wastall, Andrew M Hanby, James L Thorne, Thomas A Hughes
Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy. British journal of cancer 124 (6) (2021)
Rashmi Verma, Andrew M Hanby, Kieran Horgan, Eldo T Verghese, Milene Volpato, Clive R Carter, Thomas A Hughes
Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer. Breast cancer research and treatment 183 (1) (2020)
Waleed S Al Amri, Diana E Baxter, Andrew M Hanby, Lucy F Stead, Eldo T Verghese, James L Thorne, Thomas A Hughes
Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants. Breast cancer research and treatment 183 (3) (2020)
Annesha Chatterjee, Samir Jana, Soumya Chatterjee, Laura M Wastall, Gunjan Mandal, Nelofar Nargis, Himansu Roy, Thomas A Hughes, Arindam Bhattacharyya
MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer. British journal of cancer 121 (8) (2019)
Waleed S Al Amri, Lisa M Allinson, Diana E Baxter, Sandra M Bell, Andrew M Hanby, Stacey J Jones, Abeer M Shaaban, Lucy F Stead, Eldo T Verghese, Thomas A Hughes
Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer. Molecular cancer therapeutics 19 (3) (2019)
Samantha A Hutchinson, Priscilia Lianto, Hanne Roberg-Larsen, Sebastiano Battaglia, Thomas A Hughes, James L Thorne
ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling. Nutrients 11 (11) (2019)
Samantha A Hutchinson, Priscilia Lianto, Jennifer Bernadette Moore, Thomas A Hughes, James L Thorne
Phytosterols Inhibit Side-Chain Oxysterol Mediated Activation of LXR in Breast Cancer Cells. International journal of molecular sciences 20 (13) (2019)

Thomas A Hughes.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas A Hughes